Get started
Author

Xiao-Ting Cai

Observed names: Cai, Xiao-Ting, Xiao-ting Cai, Xiaoting Cai
Observed institutions: Binzhou Medical University, Guangdong Medical College, Shanghai Jiao Tong University, Ruijin Hospital, Tianjin Medical University Cancer Institute and Hospital, Yuhuangding Hospital, First Affiliated Hospital of Guangzhou Medical University, Nanfang Hospital, Affiliated Hospital of Qingdao University, State Key Laboratory of Respiratory Disease, Guangzhou Chest Hospital, Chinese People's Liberation Army, Guangzhou Institute of Respiratory Health, Tianjin Medical University, Southern Medical University, Jinzhou Medical University, Guangzhou Medical University
ORCID: 0000-0001-9989-3571
Observed ORCID: 0000-0001-9989-3571
OpenAlex ID: A5087983650
PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy
2025 · Yan-Pei Zhang, Ze-Qin Guo, et al. · Cancer Cell · 52
Sirtuins: Research advances on the therapeutic role in acute kidney injury
2022 · Chaoming Huang, Shisheng Jiang, et al. · Phytomedicine · 49
Progress of research on the role of active ingredients of Citri Reticulatae Pericarpium in liver injury
2023 · Shuhan Gao, Xiaojing Chen, et al. · Phytomedicine · 46
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2022 · Li-Li Long, Si-Cong Ma, et al. · Cancer Research · 37
PDF
Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study
2018 · Huaping Huang, Guosheng Yuan, et al. · Journal of Thoracic Disease · 21
PDF
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation
2023 · Xue-Jun Guo, Xiao-Ting Cai, et al. · BMC Medicine · 20
PDF
Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice
2022 · Si-Cong Ma, Xue Bai, et al. · BMC Medicine · 18
PDF
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage
2021 · Shan Su, Mei-Feng Ye, et al. · BMC Medicine · 13
PDF
High-dose ascorbic acid selectively induces pyroptosis in LKB1-deficient lung cancer and sensitizes immunotherapy
2025 · Xiangyu Sun, Xiaoting Cai, et al. · Cell Reports Medicine · 12
Tumour–pleura relationship on CT is a risk factor for occult lymph node metastasis in peripheral clinical stage IA solid adenocarcinoma
2023 · Chengzhou Zhang, Liping Wang, et al. · European Radiology · 12
Regular Use of Aspirin and Statins Reduces the Risk of Cancer in Individuals with Systemic Inflammatory Diseases
2024 · Jia-Run Lin, Duan-Duan Han, et al. · Cancer Research · 10
CT-based radiomics nomogram for predicting visceral pleural invasion in peripheral T1-sized solid lung adenocarcinoma.
2023 · Xiaoting Cai, Ping Wang, et al. · PubMed · 10
PDF
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
2023 · Junzheng Zhang, Lu Song, et al. · Journal of Cancer Research and Clinical Oncology · 9
PDF
Naringenin inhibits APAP-induced acute liver injury through activating PPARA-dependent signaling pathway
2024 · Jiepei Xu, Jiamin Chen, et al. · Experimental Cell Research · 7
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off
2026 · Si-Cong Ma, Zi-Xuan Rong, et al. · Nature Cancer · 5
Palliation of malignant esophageal stent esophagorespiratory fistula with rigid bronchoscope and Y silicone trachea stent: experience with seven patients
2024 · Qixia Wang, Yanghuan Chen, et al. · Journal of Thoracic Disease · 5
Radiotherapy disrupts ferroptosis tolerance by reducing DNMT1 levels and uncouples STING silencing in LKB1-deficient lung tumors
2026 · Yan-Pei Zhang, Fei-Fei Wu, et al. · Free Radical Biology and Medicine · 4
CT-based machine learning model integrating intra- and peri-tumoral radiomics features for predicting occult lymph node metastasis in peripheral lung cancer
2025 · Xiaoyan Lu, Fan Liu, et al. · Cancer Imaging · 4
PDF
Assessment for bone health in patients with differentiated thyroid carcinoma after postoperative thyroid-stimulating hormone suppression therapy: a new fracture risk assessment algorithm
2023 · Huiran Jia, Wei Qu, et al. · Frontiers in Endocrinology · 3
PDF
Tumor rim-specific computed tomography radiomics improves prediction of pathological complete response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer
2025 · Jingyi Yang, Fangyuan Qu, et al. · Translational Lung Cancer Research · 2
HLA diversity unveils susceptibility and organ-specific occurrence of second primary cancers: a prospective cohort study
2024 · Zi-Xuan Rong, Wei Wei, et al. · BMC Medicine · 1
PDF
Integrative Single-Cell and Spatial Transcriptomic Analyses Link Arachidonic Acid Metabolic Reprogramming to Proneural-to-Mesenchymal State Transition in Glioblastoma
2026 · Shiyun Peng, Zhenkun Wen, et al. · Biomedicines
Figure S3 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025 · Li-Li Long, Si-Cong Ma, et al.
Figure S2 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025 · Li-Li Long, Si-Cong Ma, et al.
Figure S1 from PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
2025 · Li-Li Long, Si-Cong Ma, et al.
Works count: 63
Citation count: 340
H-index: 10
I10-index: 12
Year
Topic
Type